glp-1 ra mechanism of action Current Insights, Advantages and Challenges Small Molecule Glucagon-like Peptide 1 Receptor Agonists: A Scoping Review GLP-1 receptor agonists (GLP-1RAs): cardiovascular
Description
Dulaglutide reduces binge episodes in type 2 diabetic patients with BED: a pilot study
The durability and breadth of benefits create more opportunity to escape the cycle of chronic disease
Studies note that nausea, vomiting, and delayed stomach emptying from GLP-1 RAs can reduce food variety and potentially nutrient absorption
doi: 10.3389/fphar.2021.672515
